기관절개술은 경부를 절개하여 기관에 튜브를 삽입하는 수술로 기관절개 튜브라고 합니다. 기관절개 튜브는 목구멍을 통해 기관에 직접 삽입되는 인공기도입니다. 호흡을 위한 연결을 구축하는 수단으로 상부 호흡기를 우회합니다. 기관절개관은 양압 환기를 용이하게 하고, 분비물 제거를 위한 접근을 가능하게 하며, 상기도가 막힌 환자에게 기도를 확보합니다.
기관절개술은 호흡을 위한 정상적인 경로가 어떤 식으로든 차단되거나 감소된 경우 호흡을 돕는 공기 통로를 제공합니다. 기관절개 튜브는 건강상의 문제로 호흡을 돕는 기계(인공호흡기)를 장기간 사용해야 하는 경우에 종종 필요합니다. 드물게는 얼굴이나 목에 외상을 입은 후 등 갑자기 기도가 막힌 경우 응급 기관절개술을 시행할 수도 있습니다. 기관절개술이 더 이상 필요하지 않으면 기관절개술은 치유되거나 외과적으로 폐쇄됩니다. 사람에 따라 기관절개술은 영구적일 수 있습니다.
기관절개 튜브의 발전이 증가함에 따라 예측 기간 동안 시장을 주도할 것으로 예상됩니다. 이러한 튜브의 발전은 환자에게 다양한 선택권을 제공하여 환자의 선택에 따라 선택할 수 있도록 도와줍니다. 고급 기관절개 튜브는 종종 환자의 편안함을 우선시하여 설계되었습니다. 더 부드러운 소재, 자극 감소, 인체공학적 디자인과 같은 특징은 환자의 내성과 순응도를 향상시켜 기관절개 튜브의 수용을 확대하는 데 기여할 수 있습니다.
예를 들어, 세계 의료기기 제조업체인 스미스 메디컬은 2020년 1월 기관절개 튜브 제품군에 폴리염화비닐(PVC) 기관절개 튜브 포트폴리오를 새롭게 추가했습니다. 기관절개술을 받은 환자를 치료할 때는 환자별 임상적 요구에 가장 적합한 튜브를 선택해야 합니다. 새로운 기관절개 튜브는 다양한 환자를 위한 다양한 옵션을 제공합니다.
또한, 기술 혁신은 감염, 육아종 형성, 기관 협착과 같은 기관절개 튜브와 관련된 일반적인 합병증을 해결하는 것을 목표로 합니다. 이러한 위험을 최소화함으로써 첨단 기관절개 튜브는 시술의 안전성 프로파일을 향상시켜 환자가 필요할 때 이 시술을 선택할 수 있도록 유도하고 있습니다. 천식과 같은 호흡기 질환의 증가는 기관절개 튜브에 대한 수요를 증가시키고 있습니다.
예를 들어, CDC의 2020년 국민건강영양조사(NHIS)에 따르면, 미국에는 약 2,520만 명의 성인이 천식을 앓고 있으며, 2020년에는 약 180만 명의 어린이를 포함한 1,030만 명 이상의 천식 환자가 한 번 이상 천식 발작을 경험한 것으로 나타났습니다. 보고했습니다. 따라서 급성 호흡곤란이 있는 천식 환자에게는 기관 삽관이 바람직합니다. 따라서 위의 설명에서이 시장은 시장 성장을 촉진할 것으로 예상됩니다.
또한, 재료와 디자인의 발전으로 기관절개 튜브의 기능성이 향상되고 있습니다. 여기에는 일체형 흡입 시스템, 밀폐성을 높이는 커프, 성문하 흡입 등의 기능이 포함되며, 이 모든 것이 더 나은 호흡 지원 및 관리에 기여합니다. 일부 첨단 기관절개 튜브는 개별 환자의 고유한 요구를 충족시키기 위한 맞춤형 옵션을 제공하기도 합니다.
또한, 기도 장애의 유병률 증가, 신흥 시장에서의 임상시험, 튜브에 대한 인식 증가, 첨단 기능을 갖춘 기술적으로 진보된 튜브의 개발 등은 예측 기간 동안 시장을 견인할 것으로 예상되는 요인입니다.
감염, 기복, 후두 및 기관 손상, 기관절개 튜브의 막힘, 우발적 제거, 기관 연화증, 기관 식도 누공, 기관 협착, 출혈 등 튜브와 관련된 합병증 및 위험, 숙련된 전문가 부족, 튜브의 높은 비용 등의 요인이 시장을 저해할 것으로 예상됩니다.
A tracheostomy is a surgical procedure involving making an incision in the neck to insert a tube into the trachea, which is known as a tracheostomy tube. A tracheostomy tube is an artificial airway that is surgically placed directly into the trachea through an opening in the throat. It bypasses the upper airway as a means to establish a connection for breathing. Tracheostomy tubes facilitate positive pressure ventilation, allow for access for secretion removal, and provide a patent airway for patients with obstructed upper airways.
A tracheostomy provides an air passage that helps to breathe when the usual route for breathing is somehow blocked or reduced. A tracheostomy tube is often needed when health problems require long-term use of a machine (ventilator) to help breathe. In rare cases, an emergency tracheotomy is performed when the airway is suddenly blocked, such as after a traumatic injury to the face or neck. When a tracheostomy is no longer needed, it's allowed to heal shut or is surgically closed. For some people, a tracheostomy is permanent.
The increasing advancements in tracheostomy tubes is expected to drive the market over the forecast period. The advancements in these tubes helps to provide a wide range of options for patients to choose according to the patients choice. Advanced tracheostomy tubes often come with designs that prioritize patient comfort. Features such as softer materials, reduced irritation, and ergonomic designs contribute to improved patient tolerance and compliance, leading to increased acceptance of tracheostomy tubes.
For instance, in January 2020, Smiths Medical, a global medical device manufacturer, has launched a new Polyvinyl Chloride (PVC) tracheostomy tube portfolio to its family of tracheostomy tubes. When caring for a patient with a tracheostomy, a tube should be chosen to best suit the patient's specific clinical need. The new tracheostomy tubes have options for a variety of patients.
Moreover, technological innovations aim to address common complications associated with tracheostomy tubes, such as infections, granuloma formation, and tracheal stenosis. By minimizing these risks, advanced tracheostomy tubes enhance the safety profile of the procedure, encouraging patients to opt for this intervention when needed. The increasing airway disorders such as asthma are increasing the demand for tracheostomy tubes.
For instance, according to the CDC's 2020 National Health Interview Surveys (NHIS), an estimated 25.2 million adults, including 4.2 million children, have asthma in the United States. In 2020, more than 10.3 million asthmatics, including approximately 1.8 million children, reported having one or more asthma attacks. Therefore, orotracheal intubation is preferred for asthmatic patients in acute respiratory distress. Thus, from the above statements, the market is expected to drive market growth.
Additionally, advancements in materials and design led to tracheostomy tubes with improved functionality. This includes features like integrated suction systems, cuffs for better sealing, and subglottic suctioning, all of which contribute to better respiratory support and management. Some advanced tracheostomy tubes offer customization options to meet the unique needs of individual patients.
Further, the increasing prevalence of airway disorders, increasing clinical trials, increasing awareness about the tubes and development of technologically advanced tubes with advanced features are the factors expected to drive the market over the forecast period.
Factors such as complications and risks associated with the tubes such as infection, pneumomediastinum, damage to the larynx or trachea, obstruction in the tracheostomy tube, accidental decannulation, tracheomalacia, tracheoesophageal fistula, tracheal stenosis and bleeding, lack of skilled professionals and the high cost of the tubes are expected to hamper the market.
The global tracheostomy tube market is segmented based on type, component, material, end-user and region.
The polyvinyl chloride (PVC) tubes segment is expected to hold the largest market share over the forecast period. PVC softens at body temperature, conforming to patient anatomy and centering the tube in the trachea. PVC is generally considered biocompatible, meaning it is well-tolerated by the human body. This is a crucial characteristic of materials used in the tracheostomy tubes.
Moreover, PVC tubes are also known for their flexibility, which is essential for medical tubing applications. They can be easily shaped and molded to suit the specific requirements of tracheostomy tubes. PVC is also durable and resistant to breakage, which offers wide advantages for patients using tracheostomy tubes. PVC tubes are often transparent, allows to visually inspect fluids passing through the tube. This transparency is advantageous for monitoring and assessing the patient's condition.
Furthermore, PVC can be easily sterilized, making it suitable for maintaining sterility. PVC is a cost-effective material, which is an important consideration for tracheostomy tubes. PVC is resistant to many chemicals, which is beneficial for applications where the tube may come into contact with various fluids and medications. Thus, owing to the above factors, the segment is expected to largest market share.
North America region is expected to hold the largest market share over the forecast period owing to the strong presence of major players and increasing adoption of tracheostomy tubes. North America especially the United States is home to many major players such as medical device companies manufacturing tracheostomy tubes. These companies often have well-established and extensive research and development capabilities and a strong market presence. The presence of major players actively performing in clinical trials, leads to the advancements in the tracheostomy tubes.
In addition, the region is also known for the increasing adoption of tracheostomy tubes for various airway applications. The aging population and the prevalence of respiratory conditions contribute to the growing adoption of tracheostomy tubes in the region. As the population ages, there is an increased likelihood of respiratory issues, necessitating interventions such as tracheostomy procedures by using tracheostomy tubes. The increasing adoption leads to the development of advanced tubes.
For instance, on June 21, 2023, Teleflex Incorporated, a leading global provider of medical technologies for critical care and surgery, revealed a global recall of affected batches of the below-mentioned Rusch Endotracheal Tube products. The Rusch Endotracheal Tube devices are indicated for oral or nasal intubation for airway management via insertion into a patient's tracheal via nose or mouth. Stylets are used to aid the insertion of endotracheal tubes into the trachea.
The major global players in the tracheostomy tube market include: Teleflex Incorporated, Medtronic plc, Healthcare 21 Ltd, Advin Health Care, Gcmedica Enterprise Ltd., Global Medikit Limited, Angiplast Pvt Ltd., Coloplast Group, Boston Medical Products Inc. and TRACOE medical GmbH among others.
The COVID-19 pandemic significantly impacted the global tracheostomy tube market. COVID-19 primarily affects the respiratory system, and severe cases often require intensive respiratory support. This increased the demand for ventilators and other devices including tracheostomy tubes, to assist in the management of critically ill patients.
The pandemic created unprecedented challenges to the market by temporarily disrupting many clinical trials and research activities due to the redirected focus on the COVID-19 pandemic. The pandemic also disrupted the supply chain of devices globally.
The global tracheostomy tube market report would provide approximately 69 tables, 78 figures, and 189 Pages.
LIST NOT EXHAUSTIVE